Mature Schwann cells (SCs) retain dedifferentiation potential throughout adulthood. Still, how dedifferentiation occurs remains uncertain. Results from a variety of cell-based assays using in vitro cultured cAMP-differentiated and myelinating SCs revealed the existence of a novel dedifferentiating activity expressed on the surface of dorsal root ganglion (DRG) axons. This activity had the capacity to prevent SC differentiation and elicit dedifferentiation through direct SC-axon contact.
| I N T R O D U C T I O N
Mature myelinating Schwann cells (SCs) are among the few identified somatic cells known to undergo dedifferentiation, which is a phenomenon that typically occurs after nerve injury. Dedifferentiation allows SCs to support axonal growth, repopulate regenerated axons and in turn, form new myelin to restore nerve function (Chen, Yu, & Strickland, 2007) . In fact, nerve regeneration does not occur if SCs fail to lose their myelin and undergo the series of changes that allow them to become competent to self-renew (Jessen & Mirsky, 2016) .
From the mechanistic perspective, the prevailing notion is that dedifferentiation occurs in response to specific extracellular signals, as both the reversal of the differentiated characteristics and the re-entry into the cell cycle require transcription factors that are sensitive to intracellular signal transduction cascades of diverse nature (Jopling, Boue, & Izpisua Belmonte, 2011) . Among these transcription activators, c-Jun/AP1, Notch and Pax-3 have been assigned a role in mediating the loss of myelin integrity that is typically associated with injuryinduced SC dedifferentiation (Arthur-Farraj et al., 2012; Doddrell et al., 2012; Woodhoo et al., 2009 ). Yet, the nature of the extracellular signals that drive the conversion of myelinating SCs into the immature cells are still unclear.
Recent data has indicated that transcription factors that prevent SC differentiation into myelin-forming cells, typically referred to as negative regulators of myelination, share the ability to drive dedifferentiation by counteracting pro-myelinating signals such as cyclin adenosine monophosphate, cAMP, (Jessen & Mirsky, 2008) . cAMP is sufficient to potently induce myelin gene expression and allow SCs to transition into a myelinating state (Bacallao & Monje, 2015) . By using isolated cAMP-differentiated SCs as a simplified in vitro model of the myelinating SC we found that the removal of the cAMP stimulus rather than the activation of receptor tyrosine kinases (RTKs) by growth factors such as neuregulin is sufficient to revert the differentiated characteristics and confer self-renewal capability (Monje, Soto, Bacallao, & Wood, 2010) . In continuing our search for modulators of SC differentiation using cAMP-differentiated SCs we unexpectedly came across the finding that active dedifferentiation was dependent upon the availability of factors expressed on the surface of sensory axons from the dorsal root ganglia (DRG). As such, we herein report the existence of a novel activity bound to the DRG axolemma that not only prevents the differentiation of axon-related SCs but also drives their dedifferentiation by overriding the action of cAMP and Krox-20/Egr-2, a cAMP responsive transcription factor that is considered a master regulator of myelination (Topilko et al., 1994) . We arrived to the concept of axon contact-driven SC dedifferentiation after performing a series of cellbased assays designed to evaluate the effect of both live and disrupted DRG neurite preparations on the expression of markers typical of differentiated (myelinating) SCs. We found the dedifferentiating axonal component to be a membrane-bound protein specifically expressed in DRG neurons. This component was different from the axonal growth factors responsible for axon contact-induced SC proliferation. It was active on its own, as it did not require membrane integrity or activity to drive dedifferentiation, and allowed SCs to dedifferentiate independently of RTK activation, c-Jun upregulation and mitogen-activated protein kinase (MAPK) signaling. Based on the abovementioned functional description, we reasoned that the herein described axonal dedifferentiating component encompassed the major anticipated requirements for a juxtacrine signal that negatively regulates SC differentiation and possibly myelination.
| MATERIALS A ND METHODS

| Materials, reagents and cell lines
N62'-O-Dibutyryladenosine-3',5'-cyclic monophosphate (db-cAMP) and 8-(4-Chlorophenylthio) adenosine-3',5'-cyclic monophosphate (CPT-cAMP) were from Biolog (Diego, CA). Recombinant heregulinb1 , a soluble peptide consisting of the EGF homology domain of b1-heregulin (hereafter referred to as "neuregulin") was from Genentech (South San Francisco, CA). Defined fetal bovine serum (FBS) was from HyClone (Logan, UT). Forskolin, cholera toxin, anti-CNPase (2',3'-cyclic-nucleotide3'-phosphodiesterase) and anti-b-actin were from Sigma (St. Louis, MO). S100 and glial fibrillar acidic protein (GFAP) antibodies were from DAKO (Carpinteria, CA). Myelin-associated glycoprotein (MAG) and myelin protein zero (P 0 ) antibodies were from Chemicon (Temecula, CA). Vimentin, N-cadherin and phosphorylatedAkt, -ERK, -ErbB3 antibodies were from Cell Signaling (Beverly, MA).
ErbB3, p75
NGFR and c-Jun antibodies were from Santa Cruz Biotech (Santa Cruz, CA). Minichromosome maintenance protein-2 (MCM2)
antibodies were from Bethyl Lab (Montgomery, TX). Anti-nestin was from EMD-Millipore (Darmstadt, Germany). Anti-peripheral myelin protein-22 (PMP22) was from AbCam (Cambridge, UK 
| Primary cultures of nerve-derived Schwann cells and fibroblasts
Adult rat sciatic nerve SCs were isolated from predegenerated explants, purified and expanded by a modification of a previously reported method (Morrissey, Kleitman, & Bunge, 1991) , as described recently (Bacallao & Monje, 2015) . SC cultures consisted of >98% SCs based on immunodetection of S100 and p75
NGFR
. Experiments were performed using early passage SCs (2-4 rounds of expansion) plated on poly-L-lysine (PLL)-laminin coated 24-well dishes. SCs obtained by this method are competent to differentiate in response to cAMP and form myelin upon co-culture with DRG neurons (Bacallao & Monje, 2015) .
Adult sciatic nerve fibroblasts were established from the adherent populations that migrated out of the degenerating nerve explants.
Fibroblasts were cultured on a PLL substrate and subjected to one round of expansion in DMEM-10% FBS. Cultures consisted of >90% Thy1.1 positive cells.
| Cultures of purified embryonic neurons from the dorsal root ganglia and the spinal cord
Embryonic day-15 dissociated DRG neurons were established, purified and maintained as described recently (Bacallao & Monje, 2015) . Typically, 20,000-30,000 total cells (in 40-50 ll of medium) from enzymatically dissociated DRG bodies were placed in the center of a laminin-coated 24-well dish in Neurobasal medium containing B27 supplement, 10 ng/ml nerve growth factor and 1 mM L-glutamine. Nonneuronal cells were removed by a 3-day treatment with 5-fluoro-2'deoxyuridine (10 mM). This method allows for the development of a system consisting of purified neurons localizing at high density in a small area in the center of the well. The axonal outgrowth extends radially and spans throughout the available surface. Exceptions included low density cultures which used <10,000 neuronal cells/drop as initial plating density and cultures established with an eccentric location of the droplet to create axon-free areas at the edge of the culture system. (Salzer, Williams, Glaser, & Bunge, 1980b To prepare trypsinized membranes, DRG neuron homogenates were incubated in calcium/magnesium-free phosphate buffer saline containing trypsin (30 mg/ml) for 50 min at 308C. The trypsin activity was stopped by placing the tubes on ice and collecting the membranes by centrifugation at 40,000g. Control samples were processed identically with the exception of the inclusion of trypsin in the incubation buffer. All fractions used for stimulation contained equal total protein (typically 10-20 mg). BrDU (1 mM) under the conditions described in the figure legends. In some experiments, neuregulin (10 nM) was used in combination with a mitogenic dose of forskolin (2 mM) and/or FBS (10%) to achieve a maximal response in SC proliferation. The incorporated tritium (liquid scintillation counting) or BrDU (immunofluorescence microscopy) was determined 2-3 days after stimulation, as described in (Monje et al., 2010) . The expression of the nuclear G1/S marker MCM2 (Kato et al., 2003) was used as alternative measure of proliferation.
| Proliferation assays
SC proliferation induced by contact with live axons was determined by plating purified SCs onto cultures of purified DRG neurons (established in 24-well dishes), as SCs readily undergo mitosis upon contact with sensory neurites in the absence of added mitogenic factors. For co-culture initiation, subconfluent cultures of mitogen and serum-starved SCs were trypsin-dissociated to obtain a single cell suspension that was immediately seeded (usually 100,000 cells) in a dropby-drop manner onto the neuronal cells in B27-supplemented Neurobasal medium (a medium formulation non-supportive of SC proliferation). To prevent possible detrimental effects of the treatments on the physical interaction between SCs and axons, which is a crucial prefatory step for proliferation, SCs were allowed to attach to and extend processes along the axonal surface for 4 hr prior to the addition of cAMP-stimulating agents and/or kinase inhibitors. 
| Differentiation and dedifferentiation assays
The cell permeable analog CPT-cAMP was provided at a final concentration of 250 mM to both induce and to maintain a differentiated state.
Other cAMP-stimulating agents, including forskolin (20 mM), cholera toxin (200 ng/ml) and db-cAMP (1 mM) were used in replacement of CPT-cAMP to maintain SC differentiation (Monje et al., 2010) . Cells were either analyzed for the expression of phenotypic markers, or replated for use in experimentation, 3-4 days after treatment initiation, which is the minimum time required for SCs to achieve a differentiated phenotype expressing high levels of myelin markers (Monje et al., 2009 (Monje et al., 2010) . To simplify the interpretation of results, proliferation and differentiation assays were done in parallel cultures subjected to identical experimental conditions.
Immunofluorescence microscopy was carried out as described in (Bacallao & Monje, 2015 analysis by immunofluorescence microscopy, as reported in (Andersen et al., 2016) .
| Western blots
Protein samples were prepared, subjected to electrophoresis and transferred to polyvinylidene fluoride membranes as described previously (Bacallao & Monje, 2015) . Gels were loaded with equal protein samples 
| Detection of cell surface lipids by live cell immunolabeling
The cell surface lipid antigens O1 and O4 were detected by live cell labeling (20 min, RT) with hybridoma culture supernatant produced in house. Cell labeling was followed by fixation for immunofluorescence microscopy analysis or lysis for analysis by a modified Western blot protocol (Monje et al., 2010) . The O1/O4 immunoglobulins (IgM type)
were detected by ECL after incubating the blocked PVDF membranes with antimouse-HRP. Western blot profiles shown in the figures display the 30 kDa molecular weight bands corresponding to the light chains of the IgMs.
| R E S U L T S 3.1 | Factors expressed by DRG neurons prevent SC differentiation in response to cAMP
It is well-established that contact with sensory axons from the DRG vigorously induce SC proliferation at least in part through the expression of neuregulin isoforms anchored to the axonal surface (Ratner, Hong, Lieberman, Bunge, & Glaser, 1988; Wood & Bunge, 1975) . Hence, to investigate the effect of axonal mitogens on cAMP-induced SC differentiation, we subjected axon-related SCs (and isolated SCs for compari- The medium of SC-only cultures was additionally supplemented with neuregulin (10 nM) and 10% FBS (referred to as 'mitogens') to mimic promitogenic cues present in DRG neurons. Three days after CPT-cAMP administration, the cultures were evaluated for the following markers: (1) O1 (green) to reveal the state of SC differentiation; (2) BrDU (red, insets) to reveal the location of proliferating SCs; and (3) Results were similar regardless of the type of cAMP-stimulating agent provided in the culture medium. As shown in Figure 3d -e, the use of db-cAMP (a potent cell permeable cAMP derivative), cholera toxin (an activator of the adenylyl cyclase Ga stimulatory subunit) and forskolin (a direct transmembrane adenylyl cyclase activator) supported high levels of myelin gene expression in isolated but not axon-related SCs (shown only for O1 expression). Because the expression of S100 (Figure 3a ) and O4
( Figure 1a , Supporting Information) was maintained high in axon-related SCs, we conclude that the disappearance of myelin-related markers was likely not associated with the loss of the SC phenotype per se.
A striking observation was that axon-related, cAMP-differentiated
SCs resumed proliferation in a manner similar to that of non- In addition to mitogenic factors, axons may provide a dedifferentiating stimulus that counterbalances the pro-differentiating action of cAMP.
3.3 | An activity of DRG neurons was sufficient to induce dedifferentiation and proliferation of cAMPdifferentiated SCs
We next tested whether cAMP-differentiated SCs stimulated with either intact or disrupted (homogenized) DRG neurons could maintain high levels of O1 expression and/or a cell cycle arrested state ( Figure   5 ). As a source for live neuronal cells, we used a single cell suspension of purified DRG neurons obtained by mild trypsinization (Figure 5a ,b, middle panels). DRG neuron homogenates (prepared as described in optimal for neuron-to-SC signaling leading to mitotic cell division (Monje et al., 2009) . It is thus plausible that similar to proliferation, SC dedifferentiation requires direct and extensive SC-axon contact.
| A trypsin-sensitive component from the DRG axons was responsible for dedifferentiation
Our results indicated that disrupted neurons were nearly as effective as the live ones to promote SC dedifferentiation and proliferation. (Figure 9c ). As expected based on previous findings (Salzer et al., 1980b) , the resultant DRG membrane preparations exhibited the stronger mitogenic activity (Figure 9c ).
We next sought out to investigate whether the dedifferentiating component of DRG axons was sensitive to proteolytic degradation, as research has shown that the membrane-bound mitogenic activity of DRG axons can easily be removed by trypsinization (Salzer, Bunge, & Glaser, 1980a) . Experimental data provided in Figure 9d ,e revealed that treatment of cAMP-differentiated SCs with mildly trypsinized, nonmitogenic DRG membranes continued to express high levels of O1.
The lack of BrDU incorporation by non-differentiated (Figure 9d , upper panels, and f) and differentiated SCs (Figure 9d ,e) confirmed the loss of mitogenic activity as a consequence of trypsinization. Altogether, data suggests that the dedifferentiating effect is provided by a nondiffusible membrane protein or protein complex specifically expressed on the surface of DRG neurites.
| The dedifferentiating component of DRG axons was different from the mitogenic component
The data presented above suggested that SCs exposed to an axonal environment receive at least two different types of signals through their established contact with sensory axons. These include a set of It has been clear since the 1970s that SC proliferation requires SCaxon contact (Salzer et al., 1980a; Wood & Bunge, 1975) . It is also well-established that the main component that accounts for the axonal mitogenic activity is a membrane-anchored form of neuregulin. Additionally, it has been reported that cultured DRG neurons exhibit constitutive expression of several members of the neuregulin-1 family, the most prominent of which are neuregulin-1 type I and neuregulin-1 type III (Zhang et al., 2006) . Because soluble neuregulin does not antag- . Western blot analysis was performed in parallel samples (c) using several markers known to discriminate between differentiated (left panels) and immature (right panels) SCs. Two concentrations (10 and 20 mg) of disrupted neurons were assayed (referred to as 13 and 23 in the figure). Densitometric data (optical density) for the expression of myelin markers is presented in panel D to illustrate the relative, dose-dependent changes in each individual marker derived cell line PC12, which are enriched in cell surface mitogens for SCs (Ratner, Glaser, & Bunge, 1984) , were used as stimuli (not shown).
Compelling data has indicated that the activation of RTKs from the ErbB family, more specifically the activation of the tyrosine kinase activity of heterodimers composed of ErbB2 and ErbB3, mediate the mitogenic response of SCs to soluble neuregulin and axon contact stimulation (Morrissey, Levi, Nuijens, Sliwkowski, & Bunge, 1995) . The activation of ErbB2 was also shown to mediate injury-induced c-Jun up-regulation, Krox-20 down-regulation and consequent myelin loss in models of Wallerian degeneration carried out in vitro (Guertin, Zhang, Mak, Alberta, & Kim, 2005) and in vivo (Shin et al., 2013) . Therefore, to examine whether ErbB2 activity was required for axon-induced SC dedifferentiation, we evaluated whether inhibition of ErbB tyrosine kinase activity would antagonize DRG axon-induced O1 loss ( Figure   10e ,f). For this, we used a battery of pharmacological inhibitors with demonstrated activity to prevent neuregulin-induced SC proliferation without interfering with SC survival. Among these inhibitors, we included a specific inhibitor of the tyrosine kinase activity of EGFR/ ErbB2 (referred to as ErbB2 inhibitor in figure 10e-g ), an inhibitor of the non-receptor tyrosine kinase Src (PP2) and a broad-spectrum tyrosine kinase inhibitor (genistein). Whereas all of these kinase antagonists effectively blocked DRG membrane-stimulated proliferation ( Figure   10e ,f, BrDU incorporation), none of these inhibitors prevented O1 loss Cumulatively, these results indicate that a protein constituent of DRG axons, which seems to differ from neuregulin, accounts for the effect of DRG axons on SC dedifferentiation. Thus far, our data shows that axon-induced SC proliferation rather than dedifferentiation relied on ErbB activation and its downstream tyrosine kinase signaling.
3.9 | Axon-induced SC dedifferentiation was independent of ERK and JNK activity, Krox-20 downregulation and c-Jun expression
It has been argued that the Krox-20/c-Jun ratio is reverted as SCs lose their myelin and dedifferentiate after injury at least in part via activation of MAPK family members. These MAPKs include the c-Jun N-terminal kinase (JNK), which is the upstream activating kinase for c-Jun, the extracellular signal-regulated kinase (ERK) and the stress-activated p38-MAPK [reviewed in (Lee, Shin, & Park, 2014) ]. In cAMPdifferentiated SCs, the Krox-20-to-c-Jun reversion occurs upon withdrawal of the cAMP stimulus (Monje et al., 2010) . As shown in Figure   11a , middle lanes, and b, cAMP removal from the culture medium By using pathway selective JNK (SP600125) and MEK-ERK (U0126) inhibitors, we previously showed that cAMP removal promoted c-Jun re-expression and dedifferentiation through a JNKdependent, ERK-independent mechanism of action (Monje et al., 2010) . Therefore, we herein used SP600125 and U0126 to test whether they could prevent the loss of O1 that results from exposure to the axonal stimulus provided by disrupted (Figure 12a , upper panels, and b) or live ( Figure 12a , lower panels) DRG neurons. SP600125
inhibited O1 loss and c-Jun re-appearance after cAMP removal (Figure 12a , middle panels, and b) but not in response to neurite stimulation (Figure 12a,b) . In cultures of non-differentiated SCs, both SP600125 and U0126 reduced neuregulin-induced SC proliferation (Figure 12c , SC-only). Nevertheless, we found no evidence indicating that these inhibitors could prevent the disappearance of O1 or any other feature associated with dedifferentiation under our experimental conditions (Figure 12a,b) . Likewise, the p38-MAPK inhibitor It is possible that multiple steps of mechanistically uncoupled regulatory events and context-specific signals are required as SCs progress from a myelinating to an immature (denervated) stage (Heinen, Lehmann, & Kury, 2013) .
| Conclusions and perspectives
The unique regenerative capacity of the PNS is at least in part due to the SC's ability to dedifferentiate. Adult peripheral nerves are devoid of SC precursors. Therefore, dedifferentiation of preexisting mature SCs 
